secwatch.observer — SEC 8-K summary
======================================

Issuer:     INCYTE CORP (INCY)
CIK:        0000879169
Form:       8-K
Filed at:   2026-06-22T11:00:40+00:00
Accession:  0000879169-26-000046
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Incyte settles CMS dispute over Opzelura Medicaid rebates; records $246M benefit
--------------------------------------------------------------------------------

- CMS will not apply line extension regulation to Opzelura as if it were a line extension of Jakafi; Incyte withdraws lawsuit.
- One-time non-cash benefit of ~$246M in Q2 2026 from reversal of previously accrued liabilities through March 31, 2026.
- No future accruals for potential line extension regulations; expects improvement to Opzelura's gross-to-net.
- Company plans to update financial guidance on next scheduled earnings release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/0000879169-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/incy-20260622.htm
  HTML page:      https://secwatch.observer/filing/0000879169-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer